The equity benchmark indices on Monday, March 10, were trading positively during the afternoon trade, supported by firm trends in Asian markets.
At 12:25 PM, the S&P BSE SENSEX was trading at 74,511.74, rising 179.16 points, or 0.24%, while the NSE's NIFTY50 index was at 22,589.15, up 36.65 points, or 0.16%.
Here is a list of stocks that are buzzing in today's trade.
IndusInd Bank: Shares of the private sector lender IndusInd Bank fell as much as 5.38% to hit a fresh 52-week low of ₹886.40 on the BSE after the Reserve Bank of India (RBI) granted only a one-year extension to Sumant Kathpalia, managing director (MD) and chief executive officer (CEO) of IndusInd Bank, despite the bank's board requesting a three-year reappointment, according to news reports.
The bank, in a stock exchange filing post-market hours on Friday, said, "The Reserve Bank of India, via its letter dated March 6, 2025, has conveyed its approval for the re-appointment of Sumant Kathpalia as MD & CEO of the bank for a further period of one year with effect from March 24, 2025, till March 23, 2026."
During the intraday trade, IndusInd Bank shares traded 3.08% lower at ₹907.9 apiece, underperforming the NIFTY50 index, which was up 0.36%.
Read moreLupin: Shares of drug manufacturer Lupin surged over 2.5% on Monday, March 10, after the company got final nod from the US FDA to launch Rivaroxaban tablets USP in the US market.
In an exchange filing dated March 7, Lupin informed that Rivaroxaban Tablets USP, 2.5 mg, had estimated annual sales of $446 million in the US. The drug is a bioequivalent to Xarelto Tablets, 2.5 mg of Janssen Pharmaceuticals, Inc. It is used to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) and the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularisation due to symptomatic PAD.
At 10:14 AM, shares of the pharma major were trading at ₹2,038, rising 0.39% on the National Stock Exchange (NSE). Its market capitalisation stands at ₹93,043.04 crore.
Read moreGensol Engineering: Shares of Gensol Engineering fell as much as 4.38% to ₹308 apiece on the NSE on Monday, March 10, after a series of developments at the company last week.
The stock, which has been reeling under pressure after credit rating downgrades by CARE and ICRA, announced on Friday, March 7, that the company's promoters have sold approximately 2.37% of total equity shares of the company, amounting to 9,00,000 shares, to unlock liquidity that will be reinvested into the business through equity infusion. This step is part of a strategy aimed at reinforcing the company’s balance sheet and supporting stability, it said.
During intraday trade, shares of Gensol were trading at ₹310.55, declining 3.53% on the National Stock Exchange.
Read moreJSW Steel: Shares of JSW Steel surged over 2% during the morning trade on Monday, March 10, as the steel producer reported a 12% year-on-year rise in the consolidated steel production to 24.07 lakh tonnes for the month of February.
From its India operations, the company saw a 13% increase in steel production year-on-year (YoY) to 23.32 lakh tonnes as compared to 20.50 lakh tonnes reported in February 2024. JSW Steel US steel production stood at 0.75 lakh tonnes during the reporting period.
At 10:45 AM, JSW Steel shares were trading at ₹1,029.85 apiece, rising 1.85% on the National Stock Exchange (NSE). The company’s market capitalisation stands at ₹2.51 lakh crore.
Read moreAjax Engineering: Shares of leading concrete equipment manufacturer Ajax Engineering rose as much as 2.9% to ₹620 apiece on the National Stock Exchange (NSE) after the company announced financial results for the third quarter ended December 2024.
At 10:11 am, the stock was up 0.50% to ₹605.35 per share on the NSE. Its market capitalisation stood at ₹6,925.62 crore.
Ajax Engineering posted a 26.3% increase in its net profit to ₹681.26 crore in the latest December quarter, compared to ₹539.38 crore in the corresponding period last fiscal. Revenue from operations increased 37.26% to ₹5,481.78 crore in the third quarter of the financial year 2024-25, as against ₹3,993.45 crore in the year-ago quarter.
Read moreHFCL: Shares of technology company HFCL rose on Monday, March 10, after the company's subsidiary bagged an order from the Indian Army.
The stock climbed 1.16% to ₹84.84 per share on the National Stock Exchange (NSE) at 9:20 am. Its market capitalisation stands at ₹12,239.64 crore.
In an exchange filing, the company informed that its material subsidiary, HTL Ltd, has received a contract worth ₹44.36 crore from the Indian Army to supply tactical optical fibre cable assemblies. This made-in-India-manufactured solution features optical fibre cables that can withstand heavy armoured vehicle loads and is fitted with specialised military-grade connectors developed for harsh and demanding environments, it said.
Read moreInfosys: Infosys, India’s second-largest IT services company, has received an upgrade from international equity research firm CLSA. CLSA upgraded Infosys following a recent correction in stock price and on-ground demand largely remaining unchanged. The announcement led to a surge in Infosys shares, rising as much as 1.95% to hit an intraday high of Rs 1,719.
Infosys shares have corrected 16% from their 52-week high of ₹2,006.45 they touched on December 13, 2024, data from the National Stock Exchange showed.
CLSA’s upgrade is driven by Infosys' strong positioning in the IT sector, particularly in the wake of discretionary revival across key geographies and verticals. CLSA noted that conversations with various company management teams, including Infosys, indicated that there was no material change in demand outlook for Q4FY25.
Read moreBodal Chemicals: Shares of Bodal Chemicals jumped as much as 14.5% to ₹64.97 apiece on the BSE in the early trade on Monday, March 10.
The company last week said that the Ministry of Finance (Department of Revenue) has issued a notification, published in the Gazette of India, Extraordinary, Part II, Section 3, Subsection (i), dated 07 March 2025 (enclosed as Annexure A), recommending the imposition of an anti-dumping duty on imports of Trichloroisocyanuric Acid” (“TCCA”), falling under tariff items 2933 69 10 or 2933 69 90 of the First Schedule to the Customs Tariff Act, 1975, originating in, or exported from, China PR and Japan.
"Further, we hereby also inform you that Bodal Chemicals Limited is producing TCCA at its Unit 11, located in Neja, Khambhat. Furthermore, as of now, Bodal Chemicals Ltd is the only producer of TCCA products in India," the company said in its exchange filing.
Read moreSun Pharma: Shares of Sun Pharma surged as much as 1.99% to ₹1,641.45 apiece on the NSE on Monday, March 10, as the company today announced that the pharma major has entered into an agreement with Checkpoint Therapeutics, by which it will acquire Checkpoint, an immunotherapy and targeted oncology company.
When last checked, the stock was trading 0.5% higher at ₹1,617.50 on the NSE.
Checkpoint is a Nasdaq-listed commercial-stage company focused on developing novel treatments for patients with solid tumour cancers. Checkpoint has received approval from the US Food & Drug Administration (FDA) for UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation.
Read moreBharat Electronics: Shares of the BEL surged over 2% on Monday ahead of its interim dividend announcement. The state-run company has fixed Tuesday, March 11, as the record date for payment of ₹1.5 per share interim dividend for the financial year 2024-25 (FY25).
Global brokerage firm Jefferies also increased its outlook for the firm, according to news reports.
At 12:17 PM, shares of Bharat Electronics (BEL) were trading 0.06% higher at ₹277.17 apiece on NSE.
Read more
